热门资讯> 正文
Merit Medical将以2200万美元收购C2 CryoBalloon技术
2025-10-16 05:29
- Merit医疗系统(MMSI) 0
- 鲍尔包装(BLL) 0
- 纳比特(NA) 0
- Merit Medical Systems (NASDAQ:MMSI) announced on Wednesday a definitive asset purchase agreement with Pentax to acquire the C2 CryoBalloon technology for $22 million, consisting of a $19 million cash payment at closing and potential contingent payments of up to $3 million payable upon meeting certain milestones.
- The closing of this transaction is expected during the fourth quarter of 2025.
- The proposed acquisition would expand the company's endoscopy portfolio with an innovative device to treat patients suffering from Barrett's esophagus and other gastrointestinal disorders.
- The company has also expected that the asset acquisition would contribute $6M to $8M of revenue and non-GAAP earnings per share ranging from $0.02 to $0.03 per share and GAAP earnings per share ranging from $0.03 to $0.05 per share.
More on Merit Medical Systems
- Merit Medical Has To Rebuild Some Confidence In The Growth Story
- Merit Medical Systems outlines 2025 revenue guidance of 10–11% growth and updates WRAPSODY reimbursement timeline
- Seeking Alpha’s Quant Rating on Merit Medical Systems
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
